Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Everything arrived sealed with lab reports, and Ive had consistent results
MECHANISM CATEGORIES RESEARCH CONDITIONS SAFETY Side effects Limited human safety data Animal toxicology shows wide therapeutic window Injection-site reactions reported anecdotally Known interactions Anticoagulants (theoretical, due to angiogenic activity unstudied) Contraindications Active malignancy (theoretical, due to angiogenic mechanism) Pregnancy/lactation (unstudied) REGULATORY STATUS FDA Placed on FDA Category 2 of the 503A bulks list (September 2023 update), barring compounding pharmacies from preparing it under section 503A
Yin B-K, Lzaro D, Wang Z-Q
Since BPC-157 promotes overall tissue repair, once the effects are noticed, they will typically stay in place, with most patients noticing long-term healing effects for months to come
(3) EHR Patient ID
Rights and permissions Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material
US$ 27.87
US$ 24.47
US$ 21.04
US$ 28.95
US$ 28.53
US$ 26.89
US$ 23.54
